ArticleThe Journal of international medical research2021
Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice.
Fei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.